Linagliptin 5 mg & Dapagliflozin ,,, ...

Linagliptin 5 mg & Dapagliflozin 
LINALIGLIP DAPA 
Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor.
Mechanism of Action: It works by inhibiting the enzyme DPP-4, which increases the levels of active incretin hormones. This, in turn, stimulates the release of insulin and reduces the production of glucose by the liver.
Indications: Linagliptin is used to improve glycemic control in adults with type 2 diabetes.
Dapagliflozin:

Class: Dapagliflozin is a sodium-glucose co-transporter 2 (SGLT-2) inhibitor.
Mechanism of Action: It works by inhibiting SGLT-2, a protein responsible for the reabsorption of glucose in the kidneys. By blocking this reabsorption, dapagliflozin promotes the excretion of excess glucose in the urine, leading to reduced blood glucose levels.
Indications: Dapagliflozin is used to improve glycemic control in adults with type 2 diabetes.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 5 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
info@sterispharma.com
order now: https://www.sterisonline.com/product/linaliglip-dapa-5-10-134320